Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Neoplasm, Residual × Neoadjuvant Therapy × Clear all

Phase

Phase NA 1 Phase 2 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 38 Colorectal Neoplasms 24 Carcinoma, Non-Small-Cell Lung 18 Rectal Neoplasms 14 Lung Neoplasms 13 Esophageal Neoplasms 9 Stomach Neoplasms 8 Esophageal Squamous Cell Carcinoma 8 Colonic Neoplasms 8 Carcinoma, Hepatocellular 8 Prostatic Neoplasms 7 Pancreatic Neoplasms 7 Ovarian Neoplasms 7 Neoplasm Metastasis 7 Adenocarcinoma Of Esophagus 7 Squamous Cell Carcinoma of Head and Neck 6 Neoplasms 6 Osteosarcoma 5 Liver Neoplasms 5 Sarcoma 4 Inflammatory Breast Neoplasms 4 Head and Neck Neoplasms 4 Fallopian Tube Neoplasms 4 Breast Neoplasms, Male 4 Urinary Bladder Neoplasms 3 Turcot syndrome 3 Multiple Myeloma 3 Locally Advanced Rectal Cancer 3 Kidney Neoplasms 3 Carcinoma, Renal Cell 3

Interventions

blinatumomab 7 Cyclophosphamide 6 Rituximab 5 Lenalidomide 5 Dexamethasone 5 Azacitidine 5 venetoclax 4 fludarabine 4 fludarabine phosphate 3 Cytarabine 3 tislelizumab 2 thymoglobulin 2 obinutuzumab 2 daratumumab 2 Whole-Body Irradiation 2 N,N-dicyclohexyl-isoborneol-10-sulfonamide 2 Methotrexate 2 Melphalan 2 Immunotherapy 2 Imatinib Mesylate 2 Docetaxel 2 Decitabine 2 Clofarabine 2 Cladribine 2 Calcium Dobesilate 2 Busulfan 2 treosulfan 1 trastuzumab deruxtecan 1 tisagenlecleucel 1 talquetamab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00551577 2007-10-31

PRIMOVAR-1

University Hospital, Bonn

Phase 2 Unknown

Ovarian Neoplasms, Neoplasm, Residual

Data powered by HemOnc (CC BY 4.0) Colophon ⚡